PRSS2 and acute pancreatitis: The aim of this study was to conduct an in-depth and integrative analysis of the clinical value of early (24-h) assessments of trypsinogen activation peptide (TAP) and trypsin-2 in serum and urine in individuals with acute pancreatitis (AP).